MedTrace Logo

Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.

NCT00276432 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2010-01-28

No results posted yet for this study

Summary

The primary outcome in this study will be time to discharge for low-risk patients and therapeutic turnaround time for patients with NSTEMI or unstable angina.

Conditions

  • Unstable Angina
  • Non-ST-Elevation Myocardial Infarction

Interventions

DEVICE

iSTAT point of care analyzer

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • University of Cincinnati

    collaborator OTHER

  • William Beaumont Hospitals

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Wyatt W. Decker, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00276432 on ClinicalTrials.gov